钙蛋白酶Ⅰ(CAPN1)基因多态性与鸡肉嫩度和屠体性状的相关研究

为了探讨CAPN1基因作为影响鸡肌肉嫩度候选基因的可能性, 寻找与鸡嫩度性状相关的分子标记, 对钙蛋白酶Ⅰ(CAPN1)基因的CDS区进行SNPs 检测, 分析不同基因型在5个优质肉鸡纯品系和3个配套系间分布规律。利用测序和单链构象多态(SSCP)的方法进行SNPs 检测和基因型的分析, 计算等位基因频率、各位点多态信息含量。结果发现2546位(位点A) 处发生点突变由C→T和3535位(位点B)处发生点突变由G→A。各位点的3 种基因型与肉鸡生产性状的最小二乘分析结果表明,各位点的各种基因型个体在肌纤维密度和部分屠体性状指标存在显著差异(P< 0.05)。初步推断CAPN1基因可能是影响鸡嫩度性状潜在的主效基因或与主效基因连锁, 并且这些位点具有成为分子标记的潜在可能。     

FGF5基因对内蒙古绒山羊绒毛性状的影响

根据FGF5基因已知DNA序列设计了2对引物, 采用PCR-SSCP和PCR-RFLP技术, 在内蒙古绒山羊群体中进行基因多态性检测, 结果发现FGF5基因外显子1存在限制性内切酶BglⅠ多态位点。对其不同基因型个体PCR回收产物进行测序, 测序结果发现该SNP是由碱基序列C→T的突变而引起的。基因型和基因频率统计, 该实验群体以等位基因A具有明显的优势, χ2检验表明该SNP位点的基因频率处于Hardy-Weinberg平衡状态; 对该SNP与绒毛性状关联分析, 表明该SNP对绒纤维伸直长度(P<0.01)和含绒量(P<0.05)有显著影响, 而对其他各绒毛性状的影响不显著(P>0.05)。AB基因型个体绒纤维伸直长度(P<0.01)和含绒量(P<0.05)显著高于AA基因型个体。     

山羊FGF5基因组织表达及其变异与羊绒性状的关联性分析

为了研究山羊FGF5基因的遗传变异和组织表达等分子特征及其变异对山羊羊绒性状的影响,本试验应用PCR-SSCP与测序相结合的方法检测FGF5基因第1外显子在陇东绒山羊、柴达木绒山羊和中卫山羊中的多态性,并分析该基因变异对羊绒性状的影响;采用RT-qPCR技术研究FGF5基因在陇东绒山羊和辽宁绒山羊组织中的表达.结果 表明,在山羊FGF5基因的第1外显子区检测到一个同义突变位点c.272C＞T,表现为MM、MN和NN3种基因型,其中NN型仅在陇东绒山羊中有极少量分布.3个山羊品种的优势基因型均为MM,优势等位基因均为M.c.272C＞T位点在3种山羊品种中均处于Hardy-Weinberg平衡状态,且均为低度多态.c.272C＞T位点与陇东绒山羊的羊绒性状关联性分析表明,该位点对羊绒纤维直径的影响显著.携带等位基因N的个体的羊绒纤维直径显著低于不含等位基因N的个体的(P＜0.05);基因型MN个体的羊绒纤维直径显著低于基因型MM个体的(P＜0.05).FGF5基因在陇东绒山羊和辽宁绒山羊的心、肝、脾、肺、肾、骨骼肌和皮肤中均有表达;在陇东绒山羊的心、脾、肺、肾和皮肤中的表达量显著或极显著高于辽宁绒山羊的.本研究结果提示,若以改善羊绒细度为选育目标,山羊FGF5基因可作为羊绒性状改良的候选基因.     

奶牛β-Lg基因第1外显子PCR-SSCP多态性与泌乳性能的相关性

采用PCR-SSCP技术并结合测序对233头奶牛β乳球蛋白(β-Lg)基因5’端部分序列和外显子1全部序列进行了多态性研究,分析了该基因与奶牛泌乳性状的相关性。结果表明:β-Lg基因5’端和外显子1共存在2个等位基因3种基因型,BB型为优势基因型,B为优势等位基因。该群体在这一位点上偏离Hardy-Weinberg平衡状态,多态信息含量(PIC)为0.3548。测序结果显示,与普通牛该基因序列(X14710)相比,B等位基因在2073 bp、2202 bp和2206 bp处发生了G→C、C→T和A→G的碱基突变,其中2202 bp处的C→T突变导致第11位氨基酸由苏氨酸变为异亮氨酸,而A等位基因在3个位点上与X14710相同。最小二乘法分析表明,BB型305 d乳蛋白量显著高于AA型和AB型(P<0.05);AB型305 d乳脂量显著高于AA型(P<0.05),BB型与AB型之间差异不显著(P>0.05);等位基因B为高乳蛋白量和乳脂量的优势基因,可作为奶牛选育的分子遗传标记。     

水貂GH基因SNP_S与皮张长度的相关性研究

以水貂生长激素(GH)基因作为控制水貂皮张长度性状主基因的候选基因,以大兴安岭水貂养殖基地养殖的水貂群为试验材料,通过PCR-SSCP方法对GH基因进行多态性检测。在该基因内含子1中发现1处碱基突变:C→A,并检测到3种基因型(AA、AB、BB),BB基因型个体与AA基因型个体皮张长度有一定的差异(P0.05)。在外显子2中发现2处碱基突变:T→A、C→G,并由此检测到了3种基因型,分别命名CC、CD、DD,但3种基因型对水貂皮长的影响没有显著的差异(P0.05)。统计各基因型之间的组合给水貂皮长带来的影响时,发现多数组合基因型对所检测的水貂皮长有显著影响(P0.05)。     

5-羟色胺受体基因多态性位点与海洛因依赖的关联性研究

目的：5-HT（5-hydroxytryptamine,5-HT）参与了多种中枢神经活动的生理过程,其功能异常可以影响很多行为障碍,已有研究显示,5-HT水平与多种精神疾病密切相关。5-HT受体及其转运体基因在海洛因依赖发生发展中起到了重要的作用,是海洛因依赖的主要候选基因。探讨5羟色胺2A受体（Serotonin 2A receptor,HTR2A）基因启动子区-1438A/G（rs6311）、外显子区102T/C（rs6313）与5羟色胺1B受体（Serotonin 1B receptor,HTR1B）基因外显子区861G/C（rs6296）3个单核苷酸多态性和海洛因依赖的关联性分析。方法：严格按照诊断标准,选取无亲缘关系的海洛因依赖个体616例及健康个体600例提取基因组DNA,采用PCR-RFLP方法检测rs6311、rs6313和rs6296 3个SNPs位点的基因型频率,采用SPSS16.0软件分析各位点等位基因、基因型频率在病例-对照组间差异。结果：HTR2A基因rs6311和HTR1B基因rs6296位点的等位基因及基因型频率分布在2组间存在统计学差异（P〈0.05）,病例组rs6311位点的等位基因A频率显著高于对照组（X2=5.436,P=0.020,OR=1.208,CI=1.031~1.417）,rs6296位点的等位基因C频率显著高于对照组（X2=12.116,P=0.000,OR=1.329,CI=1.132~1.560）。连锁不平衡检验结果显示,HTR2A基因rs6311、rs6313位点处于不连锁状态,D＇〈0.5。结论：HTR2A基因rs6311和HTR1B基因rs6296多态性可能与海洛因成瘾有关,携带有rs6311 A等位基因与rs6296 C等位基因的人可能更容易对海洛因产生依赖。我们的研究为海洛因依赖易感人群筛选及药物靶向治疗提供了理论依据。     

高山美利奴羊INHA基因多态性生物信息学分析及与产羔数关联分析

本研究旨在研究高山美利奴羊INHA基因外显子多态性及其与产羔数的相关性。本实验通过比对高山美利奴羊全基因组测序结果中不同个体INHA外显子,分析高山美利奴羊INHA基因的单核苷酸多态性,应用生物信息学软件分析高山美利奴羊INHA基因突变前后不同等位基因的m RNA二级结构、蛋白质的二级结构及三级结构。通过上述分析,将引起高山美利奴羊INHA编码氨基酸变化的位点作为该基因的特异性候选位点,通过直接测序法分析高山美利奴羊特异性候选位点INHA基因多态性,并分析其与产羔数的相关性。结果发现,高山美利奴羊INHA基因外显子区域存在3个SNPs,分别为T206A (Met→Lys)、T387A(Thr→Thr)、G900A (Pro→Pro);INHA基因3个SNPS都改变了RNA的最小自由能以及二级结构,错义突变T206A (Met→Lys)引起蛋白质二级结构和三级结构的改变;高山美利奴羊INHA基因T206A突变表现出3种基因型分别命名为TT、TA、AA,基因型与产羔数关联分析发现TT、TA基因型个体的产羔数极显著高于TT基因型个体(p<0.01)。本研究初步表明INHA基因是影响高山美利奴羊产羔数的一个主效基因。     

贵州黑山羊STAT5A基因多态性及其与生长性状关联分析

目的:探讨STAT5A基因SNP与贵州黑山羊生长性状关联性,旨在为山羊选种选育提供更好的科学依据。方法:以贵州黑山羊为研究对象,采用DNA池法及PCR-SSCP技术检测STAT5A基因单核苷酸多态性。结果:贵州黑山羊STAT5A基因内含子6和外显子7分别检测到1个SNP位点T-90C和C+69T,位点T-90C为2种基因型,分别命名为CC和TC。基因型与生长性状关联分析显示,贵州黑山羊TC基因型个体的胸围显著高于CC基因型个体(P0.05),而其余4个指标均差异不显著(P0.05);实验山羊群体基因频率和基因型频率处于哈代-温伯格平衡状态(P0.05)。结论:研究结果提示:STAT5A基因可能是影响山羊胸围的主效基因或与主效基因连锁,T-90C位点可望作为提高山羊个体生长性能的分子遗传标记。     

甘肃河西地区西门塔尔杂交类群NGB基因第3外显子的遗传变异研究

旨在对甘肃河西的临泽、甘州、武威、金昌、高台5个地区283头西门塔尔杂交类群NGB基因第3外显子的遗传多态性及变异特征进行系统分析,采用PCR-SSCP方法检测了283头西门塔尔杂交类群NGB基因第3外显子和部分内含子的多态性,且对群体内各等位基因进行了测序。结果显示,5个地区西门塔尔杂交类群共检测出5个等位基因(A、B、C、D、E),表现为5种基因型(AA、AB、AC、AD、AE)。其中甘州、武威、金昌西门塔尔杂交类群NGB基因均只检测到AA、AB 2种基因型,高台西门塔尔杂交类群检测到AA、AE 2种基因型,临泽西门塔尔杂交类群检测到AA、AB、AC、AD 4种基因型。A等位基因和AA基因型的频率在5个群体中最高,为优势基因和优势基因型。对不同SSCP带型的对应片段进行测序分析,共发现6个核苷酸突变位点(75 bp C→T,78 bp C→G,128 bp G→A,214 bp G→A,232 bp C→T,233 bp G→A),其中第75 bp和第78 bp处的突变位点位于内含子区域,其余4处突变位点均位于外显子区域。第214 bp处的核苷酸突变导致甘氨酸(Gly)突变为丝氨酸(Ser),第232 bp处核苷酸突变导致精氨酸(Arg)突变为色氨酸(Trp),第233 bp处核苷酸突变导致精氨酸(Arg)突变为谷氨酰胺(Gln),经χ2检验结果显示,5个地区的西门塔尔杂交类群在此3个突变位点上都处于Hardy-Weinberg平衡状态(P0.05)。群体遗传学分析结果表明,临泽、甘州、武威、金昌、高台西门塔尔杂交类群的多态信息含量(PIC)分别为0.0582、0.0196、0.0196、0.0161、0.0159,均属于低度多态(PIC0.25)。     

合作猪SLA-DQA基因第4外显子多态性分析

合作猪的MHC-DQA基因的适应性变异,其抗原识别区域(即外显子4)通过PCR扩增和随后的单链构象多态性(SSCP)和序列分析,结果显示在439个合作猪个体,SLA-DQA第4外显子检出4个等位基因和6个基因型(AA、BB、DD、AB、AC和AD),其中A等位基因和AA基因型的频率最高,为优势基因和优势基因型。对不同型的PCR-SSCP条带测序分析,发现7个突变位点(5 068 bp T→C,5 109 bp和5 149 bp处缺失C,5 131 bp A→G导致丝氨酸变为甘氨酸,5 135 bp C→T,5 234 bp G→A,5 136 bp处插入A)。遗传学分析发现,合作猪多态信息含量(PIC)为0.240 1,属于低度多态,各种基因型的分布不显著。研究结果证实,合作猪SLA—DQA基因第4外显子为低度多态。     

A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3' splice site selection.

The molecular basis of a dramatically decreased steady state level of beta-hexosaminidase beta subunit mRNA in a patient with juvenile Sandhoff disease was investigated. Nucleotide sequence analysis of the HEXB gene coding for the beta subunit revealed two single base substitutions, one in exon 2 (A to G, a known polymorphism) and the other in exon 11 (C to T). Analysis of the beta subunit mRNA species demonstrated activation of a cryptic splice site in exon 11 as well as skipping of the exon. A transfection assay using a chimeric gene containing intron 10 flanked by cDNA sequences carrying the mutation confirmed that the single base substitution located at position 8 of exon 11 inhibits the selection of the normal 3' splice site. The results demonstrate a new type of exon mutation affecting 3' splice site selection.     

A second transthyretin mutation at position 33 (Leu/Phe) associated with familial amyloidotic polyneuropathy

Genomic DNA was isolated from peripheral blood lymphocytes of a patient with familial amyloidotic polyneuropathy (FAP) and the transthyretin (TTR) gene examined for sequence mutations. Polymerase chain reaction was used to asymmetrically amplify the TTR exons. Direct DNA sequencing of the PCR product revealed a C for T mutation at the first base of codon 33 located in exon 2 of one transthyretin gene. This resulted in a substitution of leucine for phenylalanine at position 33. Exons 3 and 4 were examined and found to be normal. The mutation creates a novel DdeI restriction site at the point of the mutation.     

Genetic defect in muscle phosphofructokinase deficiency. Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5'-splice site

The genetic defect in muscle phosphofructokinase deficiency (type VII glycogenosis, Tarui disease) was investigated. Six cDNAs for muscle phosphofructokinase, including a full-length clone, were isolated from a non-amplified library of muscle from a patient. By sequence analysis of these clones, a 75-base in-frame deletion was identified. The rest of the sequence was identical to that of the normal cDNA, except for a silent base transition at position 516 (ACT (Thr) to ACC (Thr]. The deletion was located in the 3'-terminal region of exon 13 (numbered with reference to the rabbit muscle phosphofructokinase gene (Lee, C.-P., Kao, M.-C., French, B.A., Putney, S.D., and Chang, S.H. (1987) J. Biol. Chem. 262, 4195-4199]. Genomic DNA of the patient was amplified by polymerase chain reaction. Sequence analysis of the amplified DNA revealed a point mutation from G to T at the 5'-end of intron 13. This mutation changed the normal 5'-splice site of CAG:GTATGG to CAG:TTATGG. A cryptic splice site of ACT:GTGAGG located 75 bases upstream from the normal splice site was recognized and spliced in the patient.     

中国荷斯坦牛CVM的基因检测及其与产奶性状的关联分析

脊椎畸形综合征(Complex vertebral malformation, CVM)是由位于牛第3号染色体(BTA3)的SLC35A3基因外显子4的一个单碱基突变(G559T)所致。该致病基因在世界许多国家的荷斯坦牛群中都有一定的比例。文章对北京地区38头优秀种公牛进行分析, 发现了4头携带者, 进而检测了这些携带者公牛的555头女儿的基因型, 其中携带者占检测母牛数的44.0%。此外, 关联分析结果表明, 携带者母牛与非携带者母牛的生产性能之间存在显著差异(P<0.01)。携带者母牛的5个产奶性状育种值均显著高于非携带者, 泌乳持续力和体细胞评分SCS的育种值也比非携带者略高。CVM致病基因可能与BTA3上影响产奶性状的QTL或基因连锁。因此, 建议生产中对CVM携带者进行逐步淘汰     

Identification of novel SNPs in the Sarda breed goats POU1F1 gene and their association with milk productive performance

The aim of the study was to detect polymorphism in the POU1F1 gene in Sarda breed goat, as well as to establish if SNPs could be associated with milk productive traits. The research was conducted on 129 Sarda breed goats from 4 to 5 years old, multiparous, lactating and in their third to fifth lactation. We report nine exonic and seven non-coding regions SNPs within the Sarda goat POU1F1 gene, namely, Ex 1 61 G>C; Ex 1 108 G>A; Ex 3 C>T; Ex 3 92 C>T; Ex 4 110 A>G; Ex 5 34 G>A resulting in Arg213Lys change; IVS4 641 G>A, IVS4 643 A>C, IVS4 659 G>A, IVS4 677 A>C, IVS4 G699Del, IVS4 709 C>G, Ex 6 17 G>A resulting in Arg228Ser change, Ex 6 58 G>T, Ex 6 172 T>C, 3′UTR 110 T>C. A statistically significant association was found between genotype TT, in position 17 of the exon 6 (3.1 % of frequency), and increased milk yield (P < 0.01) while genotype GT (25.6 % of frequency) was associated with a higher fat content. Genotype TT in position 58 of the exon 6 (3.9 % of frequency) was found to be associated with a higher fat (P < 0.01) and protein content (P < 0.05). Twenty-eight haplotypes were detected, but no significant association between the haplotypes and the milk production traits have been found. Our data, as well as providing new SNPs extending the POU1F1 gene characterization, evidence a relationship between polymorphism and milk production traits in Sarda goat breed.     

The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations.

Four new mutations in the cystathionine beta-synthase (CBS) gene have been identified in Italian patients with homocystinuria. The first mutation is a G-to-A transition at base 374 in exon 3, causing an arginine-to-glutamic acid substitution at position 125 of the protein (R125Q). This mutation has been found in homozygosity in a patient partially responsive to pyridoxine treatment. The second mutation is a C-to-T transition at base 770 in exon 7, causing a threonine-to-methionine substitution at amino acid 257 of the protein (T257M). This mutation has been observed in homozygosity in a patient nonresponsive to the cofactor treatment. The third mutation, found in heterozygosity in a patient responsive to pyridoxine treatment, is an insertion of 68 bp in exon 8 at base 844, which introduces a premature termination codon. The fourth mutation is C-to-T transition in exon 2 at base 262, causing a proline-to-serine substitution at position 88 of the protein (P88S). This mutation is carried on a single allele in three affected sisters responsive to the cofactor treatment. In addition, six previously reported mutations (A114V, E131D, P145L, I278T, G307S, and A1224-2C) have been tested in 14 independent Italian families. Mutations A114V and I278T are carried by three and by seven independent alleles, respectively. The other four mutations--including G307S and A1224-2C, common among northern European patients--have not been detected.